2022
Broome CM, Hooda N , Su J, Jiang X , Nicholson G, Frankenfeld CL , Iglesias-Rodriguez M, Fryzek J, Patel Parija. 2022. Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States. PLoS One 17(12):e0276617; doi: 10.1371/journal.pone.0276617 . PMID: 36520848.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology
Cardosi L, Rau R, Emdem MR, Kemp R, Minshall M, Pontenani F, Provision S, Sacks N . 2022. Healthcare resource utilization in non-cystic fibrosis bronchiectasis (NCFB) patients with commercial insurance coverage in the US. Value in Health 25(12):S89-S90; doi: 10.1016/j.jval.2022.09.437 .
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Jensen I , Cyr P . 2022. Early health economic models in gene and cell therapy to inform clinical trial design and optimize commercialization efforts. White Paper. PharmaLive .
Publication: White paper
/ Topics: cost-consequence , cost-utility analysis , Health Economics and Outcomes Research (HEOR)
Yao W, Jensen I , Claussen M, Dandurand K, Buffington B, Fuentes D, Mikhael M. 2022. Health economics of selective early rescue surfactant administration and standard surfactant administration for newborns with respiratory distress syndrome. J Pediatr Pharmacol Ther 27(8):695–702; doi: 10.5863/1551-6776-27.8.695 .
View Abstract
Publication: Manuscripts
/ Topics: cost-consequence , cost-utility analysis , Health Economics and Outcomes Research (HEOR) , respiratory distress syndrome
Cohen SS, Bylsma LC, Movva N , Alexander DD. 2022. Theoretical attributable risk analysis and Disability Adjusted Life Years (DALYs) based on increased dairy consumption. BMC Public Health 22(1):1625; doi: 10.1186/s12889-022-14042-7 . PMID: 36030208.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology , Food science , risk assessment , Toxicology
Danese MD, Schenfeld J, Shaw J, Gawade P, Balasubramanian A, Kelsh M , et al. 2022. Association between granulocyte colony-stimulating factor (G-CSF) use and myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) among elderly patients with breast, lung, or prostate cancer. Adv Ther 39(6):2778–2795; doi:10.1007/s12325-022-02141-1 . PMID: 35430673.
View Abstract
Publication: Manuscripts
/ Topics: Cancer , Epidemiology
Schenfeld J, Gong T, Henry D, Kelsh M , Gawade P, Peng Y, Bradbury BD, Li S. 2022. Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy. Support Care Cancer 30(7):6327–6338; doi: 10.1007/s00520-022-06967-x . PMID: 35482126.
View Abstract
Publication: Manuscripts
/ Topics: Cancer , Epidemiology
Reichert H , Suh M , Jiang X , Movva N , Bylsma LC , Fryzek JP, Nelson CB. 2022. Mortality associated with respiratory syncytial virus, bronchiolitis, and influenza among infants in the United States: A birth cohort study from 1998 to 2018. J Infect Dis 226(Suppl 2):S246–S254; doi: 10.1093/infdis/jiac127 . PMID: 35968877.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology
Bylsma LC, Suh M, Movva N, Fryzek JP, Nelson CB. 2022. Mortality among United States infants and children under 5 years of age with respiratory syncytial virus and bronchiolitis: A systematic literature review. J Infect Dis 226(Suppl 2):S267–S281; doi: 10.1093/infdis/jiac226 . PMID: 35968871.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology , Systematic Review
Movva N, Suh M, Bylsma LC, Fryzek JP, Nelson CB. 2022. Systematic literature review of respiratory syncytial virus laboratory testing practices and incidence in United States infants and children <5 years of age. J Infect Dis 226(Suppl 2):S213–S224; doi: 10.1093/infdis/jiac203 . PMID: 35968874.
View Abstract
A Division of